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Isolation of human mesenchymal stem cells: bone 
marrow versus umbilical cord blood
We attempted the isolation and characterization of mes-
enchymal stem cells (MSCs) from bone marrow (BM) and
umbilical cord blood (UBC) in a medium with 10% fetal
bovine serum (FBS) and 10% horse serum. In the same 
conditions it was possible to isolate MSCs from bone marrow
but not from UCB.
In addition to hematopoietic stem cells, bone marrow also
contains mesenchymal stem cells1,2 which contribute to the
regeneration of mesenchymal tissues, such as bone cartilage,3
adipose, muscle, tendon, stroma and neural cells.3 The existence
of mesenchymal stem cells in cord blood is the object of intense
discussion.4-7
In this study we tried to isolate and characterize MSCs from
bone marrow and, using the same culture conditions, from UCB.
Thirty-five bone marrow and 58 full-term cord blood samples
were harvested. Mononuclear cells were isolated by a Percoll
density gradient and cultured in medium with 10% FBS and
10% horse serum. Morphology, immunophenotype and cytokine
m-RNA expression were analyzed on adherent cells at every 
passage. Some cells were cultured under conditions that were
favorable for adipogenic, chondrogenic and osteogenic differ-
entiation as described by Pittenger et al.8 Differentiated cells
were analyzed by cytochemical staining and by m-RNA specif-
ic lineage expression by reverse transcription polymerase chain
reaction (RT-PCR). Our results showed that both BM and UCB-
derived mononuclear cells, in the same culture conditions, were
able to generate an adherent layer. In BM samples the adherent
layer was initially formed by individual cells or colonies com-
posed of a few fibroblast-like cells, which rapidly reached con-
fluence and grew exponentially. BM adherent cells were 
negative for CD45, CD14 and CD34 hematopoietic antigens
(Table 1). Conversely, the number  and viability of cells in UCB
samples rapidly decreased at each passage. The UCB adherent
cell immunophenotype analysis was quite different from that of
the bone marrow analysis. Indeed, cord blood cells were CD45,
CD14, CD31 positive and CD34, CD1a, CD80 negative (Table 1).
This contrasts with results from Gutierrez et al.6 who reported
that the UCB monolayer contained at least 60% dendritic cells:
we found no evidence of dendritic cells in the UCB monolayer.
Their culture conditions, however, differed from ours because
they isolated the adherent cell population by Ficoll gradient and 
cultivated them as a dexter long-term culture.
We analyzed the m-RNA expression of two interleukins (IL-6
and IL-11) that are constitutively secreted by MSCs and are
stimulators of hematopoiesis9 and the m-RNA expression of
tumor necrosis factor-α (TNF-α) and transforming growth 
factor-β1 (TGF-β1) that are pleiotropic cytokines principally pro-
duced by monocyte-macrophages. BM adherent cells expressed
IL-6 and IL-11 but not TGF-β1 or TNF-α m-RNA. In contrast,
UCB-adherent cells expressed TGF-β1, TNF-α and IL-6. The
absence of IL-11, produced by mesenchymal cells9 confirmed
the absence of MSCs in the UCB samples. TGF-β1 and TNF-αm-
RNA, was probably expressed by monocytes-macrophages present
in the adherent UCB monolayer. Moreover, the presence of mul-
ti-nucleated cells in UCB adherent cultures that were strongly
positive for tartrase-resistant acid phosphatase (TRAP) suggested
the spontaneous differentiation of monocytes-macrophages into
osteoclasts as described by Erices et al.7
The differentiation of our cells under specific culture media
into the three lineages was demonstrated by cytochemical and
molecular analyses (Figure 1). It was not possible to induce mes-
enchymal differentiation of the UCB monolayer as the cells
grown in a specific medium died very quickly.
In conclusion, BM contained mesenchymal stem cells that
could easily be expanded and induced to differentiate for 
therapeutic use3 while the UCB adherent monolayer displayed the
morphology and the characteristics of hematopoietic cells and
not those of mesenchymal cells. Our data did not agree with the
findings of Erices et al.7 who recently identified mesenchymal
progenitor cells in 25% of their UCB harvests. It should be point-
ed out, however, that their results were obtained using a pool of
different units of pre-term UCB and, probably, in such a way as
to enhance the rather low population of MSCs in pre-term UCB.
In 75% of their samples the cord blood adherent cells 
displayed the morphology and characteristics of multinucleated
Figure 1. Photomicrographs showing BM adherent cells
induced to differentiate into osteoblasts (A and B), adipocytes
(C) and chondrocytes (D). The presence of calcium oxalates
seen with Von Kossa staining (A) and the accumulation of
intracytoplasmic alkaline phosphatase (B) showed the differ-
entiation of BM MSCs into the osteoblast lineage. Adipo-
genesis was indicated by the presence of neutral lipid vac-
uoles that stain with oil red O (C) and chondrogenesis by
hyaluronic acid (D: Alcian blue staining) in cells grown as a
pellet in the presence of TGF-β3. Magnification: 20× (A,B,D), 
100× (C).
Table 1. Immunophenotype analysis of BM and UCB adherent
monolayers.
Sample CD45 CD14 CD34
Median value Median value Median value
BM 1st passage 2.21% 1.06 % 0.00%
(n=6) (1.20-11.65%) (0.57-3.48%) (0.00-1.80%))
BM 2nd passage 1.35% 0.93 % 0.00%
(n=6) (0.00-1.70%) (range: 0.00-1.70%) (range: 0.00-0.50%))
UCB 1st passage 77.00% 17.10 % O.50%
(n=33) (21.00-98.90%) (0.00-80.00%) (r0.00-2.90%)
UCB 2nd passage 87.57% 30.50 % 0.00%
(n=18) (34.00-98.10%) (2.90-83.80%) (2.90-83.80%)
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osteoclasts, the presence of which agreed with our own findings.
Zvaifler et al.10 recently isolated cells in the elutriatrion 
fraction of peripheral blood that were able to adhere to plastic
and glass and to grow without the addition of growth factors.
Despite our findings, the encouraging results obtained by both
Zvaifler et al. on peripheral blood and Erices et al. on pre-term
UCB might be regarded as a further stimulus towards the search
for mesenchymal stem cells in UCB by varying isolation and 
culture conditions.
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